blood glucose lowering drugs	are	medication
blood glucose lowering drugs	treat	type 2 diabetes
blood glucose lowering drugs	reduce	fasting glucose
blood glucose lowering drugs	lower	post‑prandial glucose
blood glucose lowering drugs	improve	HbA1c
blood glucose lowering drugs	include	metformin
blood glucose lowering drugs	include	sulfonylureas
blood glucose lowering drugs	include	thiazolidinediones
blood glucose lowering drugs	include	DPP‑4 inhibitors
blood glucose lowering drugs	include	GLP‑1 agonists
blood glucose lowering drugs	include	SGLT2 inhibitors
blood glucose lowering drugs	exclude	insulin
metformin	is a	biguanide
metformin	decreases	hepatic gluconeogenesis
metformin	improves	insulin sensitivity
metformin	causes	lactic acidosis
metformin	contraindicated	renal impairment
sulfonylureas	stimulate	pancreatic β‑cells
sulfonylureas	cause	hypoglycemia
sulfonylureas	associated	weight gain
sulfonylureas	include	glipizide
sulfonylureas	include	glyburide
thiazolidinediones	activate	PPARγ
thiazolidinediones	improve	adiponectin
thiazolidinediones	cause	edema
thiazolidinediones	contraindicated	heart failure
thiazolidinediones	include	pioglitazone
thiazolidinediones	include	rosiglitazone
DPP‑4 inhibitors	inhibit	DPP‑4 enzyme
DPP‑4 inhibitors	increase	GLP‑1 levels
DPP‑4 inhibitors	cause	mild hypoglycemia
DPP‑4 inhibitors	include	sitagliptin
DPP‑4 inhibitors	include	saxagliptin
GLP‑1 agonists	mimic	GLP‑1 hormone
GLP‑1 agonists	stimulate	insulin secretion
GLP‑1 agonists	suppress	glucagon release
GLP‑1 agonists	cause	nausea
GLP‑1 agonists	include	exenatide
GLP‑1 agonists	include	liraglutide
SGLT2 inhibitors	block	renal SGLT2 transporter
SGLT2 inhibitors	increase	urinary glucose excretion
SGLT2 inhibitors	cause	genital infections
SGLT2 inhibitors	associated	weight loss
SGLT2 inhibitors	include	empagliflozin
SGLT2 inhibitors	include	dapagliflozin
blood glucose lowering drugs	reduce	cardiovascular risk
blood glucose lowering drugs	reduce	nephropathy progression
blood glucose lowering drugs	reduce	retinopathy progression
blood glucose lowering drugs	reduce	neuropathy risk
blood glucose lowering drugs	may cause	gastrointestinal upset
blood glucose lowering drugs	may cause	skin rash
blood glucose lowering drugs	may cause	hypoglycemia
blood glucose lowering drugs	may cause	weight change
blood glucose lowering drugs	may cause	renal impairment
blood glucose lowering drugs	may cause	bone fracture
blood glucose lowering drugs	may cause	ketoacidosis
blood glucose lowering drugs	may cause	pancreatitis
blood glucose lowering drugs	may cause	liver injury
blood glucose lowering drugs	may cause	cardiovascular events
blood glucose lowering drugs	may cause	urinary tract infection
blood glucose lowering drugs	may cause	genital infection
blood glucose lowering drugs	may cause	dehydration
blood glucose lowering drugs	may cause	electrolyte imbalance
blood glucose lowering drugs	may cause	hypokalemia
blood glucose lowering drugs	may cause	hyperuricemia
blood glucose lowering drugs	may cause	gout
blood glucose lowering drugs	may cause	anemia
blood glucose lowering drugs	may cause	thrombocytopenia
blood glucose lowering drugs	may cause	pancreatitis
blood glucose lowering drugs	may cause	allergic reaction
blood glucose lowering drugs	may cause	drug interactions
blood glucose lowering drugs	may cause	drug‑drug interaction
blood glucose lowering drugs	may cause	drug‑drug interaction with ACE inhibitors
blood glucose lowering drugs	may cause	drug‑drug interaction with diuretics
blood glucose lowering drugs	may cause	drug‑drug interaction with NSAIDs
blood glucose lowering drugs	may cause	drug‑drug interaction with metformin
blood glucose lowering drugs	may cause	drug‑drug interaction with SGLT2 inhibitors
blood glucose lowering drugs	may cause	drug‑drug interaction with GLP‑1 agonists
blood glucose lowering drugs	may cause	drug‑drug interaction with sulfonylureas
blood glucose lowering drugs	may cause	drug‑drug interaction with thiazolidinediones
blood glucose lowering drugs	may cause	drug‑drug interaction with DPP‑4 inhibitors
blood glucose lowering drugs	may cause	drug‑drug interaction with GLP‑1 agonists
blood glucose lowering drugs	may cause	drug‑drug interaction with SGLT2 inhibitors
blood glucose lowering drugs	may cause	drug‑drug interaction with metformin
blood glucose lowering drugs	may cause	drug‑drug interaction with sulfonylureas
blood glucose lowering drugs	may cause	drug‑drug interaction with thiazolidinediones
blood glucose lowering drugs	may cause	drug‑drug interaction with DPP‑4 inhibitors
blood glucose lowering drugs	may cause	drug‑drug interaction with GLP‑1 agonists
blood glucose lowering drugs	may cause	drug‑drug interaction with SGLT2 inhibitors
blood glucose lowering drugs	may cause	drug‑drug interaction with metformin
blood glucose lowering drugs	may cause	drug‑drug interaction with sulfonylureas
blood glucose lowering drugs	may cause	drug‑drug interaction with thiazolidinediones
blood glucose lowering drugs	may cause	drug‑drug interaction with DPP‑4 inhibitors
blood glucose lowering drugs	may cause	drug‑drug interaction with GLP‑1 agonists
blood glucose lowering drugs	may cause	drug‑drug interaction with SGLT2 inhibitors
blood glucose lowering drugs	may cause	drug‑drug interaction with metformin
blood glucose lowering drugs	may cause	drug‑drug interaction with sulfonylureas
blood glucose lowering drugs	may cause	drug‑drug interaction with thiazolidinediones
blood glucose lowering drugs	may cause	drug‑drug interaction with DPP‑4 inhibitors
blood glucose lowering drugs	may cause	drug‑drug interaction with GLP‑1 agonists
